$ cat ./records/gates-foundation-joins-18-million-emergency-coalition-to-deploy-w-2016.txt
Gates Foundation Joins $18 Million Emergency Coalition to Deploy Wolbachia Mosquitoes Against Zika
[RECORD.TXT] · cat --full
In 2016, the Gates Foundation joined the Wellcome Trust, USAID, and the UK Government in committing $18 million in combined emergency funding to accelerate the World Mosquito Program's Wolbachia releases in Zika-affected countries. Funding enabled rapid scale-up in Brazil, Colombia, and other nations during the Zika outbreak. Research shows Wolbachia reduces Zika virus replication in Aedes aegypti by approximately 40–60 percent, adding a Zika-blocking layer atop the established dengue-suppression effect of the technology.
Source: https://blog.providence.org/home-page/gates-foundation-helps-wage-mosquito-war-against-zika-2
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates is elected a Fellow of the Royal Society
Next →
Gates Foundation Doubles Target Malaria Investment with Additional $35 Million for CRISPR Cage Trials
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.